Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.

Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.

FGK Clinical Research GmbH opens a branch office in Berlin this month. The Berlin office will support the operative units at the German headquarters in Munich.

New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).

LSP has closed its  LSP 6 fund at the $600m hard cap. It is the largest fund ever raised in Europe focused on life sciences ventures.

Pest control specialist Biotalys NV has raised an additional €10m to its series C financing bringing its amount to €45m.

Mark Truesdale has been appointed to the position of CEO at Life Sciences company Solentim.

Researchers from German Fraunhofer IGBI have used  next-generation sequencing (NGS) to diagnosis sepsis from tiny amounts of microbial DNA in the blood. 

BioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. In contrast to common bind-wash-elute procedures, their proprietary EchoLUTION single-step technology avoids the use of inhibitory or harmful process reagents and does not require washing steps. 90% of the disposal costs are saved as well as more than 40% of the pipet tip consumption costs. The inhibitor-free DNA enables lowered time-to-result in enzyme-dependent genomic analyses such as PCR or NGS.

CTO Lars Nieba has taken over as interim CEO at Nordic Nanovectors after Eduardo Bravo’s sudden departure.